Stoller Sets Agenda As Medicines For Europe’s President

Christoph Stoller, Teva’s general manager for Germany and Austria, has just been announced as president of European off-patent industry association Medicines for Europe with a two-year mandate. In an exclusive interview, he sets out the organization’s immediate priorities.

Stoller_Christoph
Teva’s Christoph Stoller is now president of Medicines for Europe • Source: Medicines for Europe

European off-patent industry association Medicines for Europe has announced that Christoph Stoller, Teva’s general manager for Germany and Austria, has taken on the role of president of the association for a two-year term.

He takes over the role from Fresenius Kabi’s Marc-Alexander Mahl, who remains a member of the Medicines for Europe executive...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Leadership

More from Generics Bulletin